Citigroup’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-141,738
| Closed | -$44.9M | – | 4994 |
|
|
2023
Q4 | $44.9M | Buy |
141,738
+104,913
| +285% | +$33.2M | 0.03% | 339 |
|
|
2023
Q3 | $6.23M | Buy |
36,825
+17,537
| +91% | +$2.97M | ﹤0.01% | 957 |
|
|
2023
Q2 | $4.18M | Sell |
19,288
-14,120
| -42% | -$3.06M | ﹤0.01% | 1196 |
|
|
2023
Q1 | $6.07M | Buy |
33,408
+13,750
| +70% | +$2.5M | ﹤0.01% | 1032 |
|
|
2022
Q4 | $3.86M | Sell |
19,658
-7,505
| -28% | -$1.47M | ﹤0.01% | 1171 |
|
|
2022
Q3 | $6.11M | Sell |
27,163
-12,986
| -32% | -$2.92M | ﹤0.01% | 1025 |
|
|
2022
Q2 | $5.08M | Buy |
40,149
+29,839
| +289% | +$3.77M | ﹤0.01% | 1120 |
|
|
2022
Q1 | $1.31M | Sell |
10,310
-61,573
| -86% | -$7.81M | ﹤0.01% | 2109 |
|
|
2021
Q4 | $9.42M | Buy |
71,883
+49,615
| +223% | +$6.5M | 0.01% | 959 |
|
|
2021
Q3 | $2.72M | Sell |
22,268
-12,212
| -35% | -$1.49M | ﹤0.01% | 1693 |
|
|
2021
Q2 | $3.93M | Sell |
34,480
-3,557
| -9% | -$405K | ﹤0.01% | 1618 |
|
|
2021
Q1 | $4.57M | Buy |
38,037
+28,270
| +289% | +$3.4M | ﹤0.01% | 1391 |
|
|
2020
Q4 | $992K | Buy |
9,767
+1,328
| +16% | +$135K | ﹤0.01% | 2180 |
|
|
2020
Q3 | $653K | Sell |
8,439
-12,815
| -60% | -$992K | ﹤0.01% | 2100 |
|
|
2020
Q2 | $2.37M | Buy |
21,254
+10,657
| +101% | +$1.19M | ﹤0.01% | 1515 |
|
|
2020
Q1 | $763K | Buy |
10,597
+6,212
| +142% | +$447K | ﹤0.01% | 1991 |
|
|
2019
Q4 | $331K | Buy |
4,385
+4,182
| +2,060% | +$316K | ﹤0.01% | 2872 |
|
|
2019
Q3 | $3K | Sell |
203
-11,297
| -98% | -$167K | ﹤0.01% | 4920 |
|
|
2019
Q2 | $230K | Buy |
+11,500
| New | +$230K | ﹤0.01% | 3123 |
|